|
Back to products
Browse products
Approved anticancer agents
Anticancer agents in trials
Anticancer agents
in preclinical trials
Anticancer molecular libraries
Other drug agents
Drug intermediates
Bio-reagents and biochemicals
|
MedKoo product information:
LY2940680
|
MedKoo Code#: 205529
|
|
Name: LY2940680
|
|
CAS#: 1258861-20-9
Synonym: LY2940680; LY-2940680; LY2940680.
IUPAC/Chemical name:
4-fluoro-N-methyl-N-(1-(4-(1-methyl-1H-pyrazol-5-yl)phthalazin-1-yl)piperidin-4-yl)-2-(trifluoromethyl)benzamide
|
|
Chemical structure
|
Theoretical analysis
|
|
|
MedKoo Code#: 205529
Name: LY2940680
CAS#: 1258861-20-9
Chemical Formula: C26H24F4N6O
Exact Mass: 512.19477
Molecular Weight: 512.50
Elemental Analysis: C, 60.93; H, 4.72; F,
14.83; N, 16.40; O, 3.12
|
|
Availability and price:
This agent is
not in stock, may be available through custom synthesis.
To inquire quotation and lead time or to ask questions, please send email to
sales@medkoo.com to describe your needs. A representative
will respond your email shortly. We offer big discount for orders of bulk quantities.
|
|
Information about this agent
|
LY2940680 is currently being developed by Eli Lilly.
Current developer:
Eli Lilly.
1. Preparation of disubstituted phthalazine
derivatives for use as hedgehog pathway antagonists and useful in
treatment of cancer By Hipskind, Philip Arthur; Patel, Bharvin Kumar;
Wilson, Takako
From PCT Int. Appl. (2010), WO 2010147917 A1 20101223.
|
Contact MedKoo:
Email:
sales@medkoo.com
(Keyword; CAS#; MedKoo code#)
|
